Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Tissue Viability ; 26(2): 131-137, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28162862

RESUMO

It has been reported that carbohydrates confer physicochemical properties to the wound environment that improves tissue repair. We evaluated in vitro and in vivo wound healing during maltodextrin/ascorbic acid treatment. In a fibroblast monolayer scratch assay, we demonstrated that maltodextrin/ascorbic acid stimulated monolayer repair by increasing collagen turnover coordinately with TGF-ß1 expression (rising TGF-ß1 and MMP-1 expression, as well as gelatinase activity, while TIMP-1 was diminished), similar to in vivo trends. On the other hand, we observed that venous leg ulcers treated with maltodextrin/ascorbic acid diminished microorganism population and improved wound repair during a 12 week period. When maltodextrin/ascorbic acid treatment was compared with zinc oxide, almost four fold wound closure was evidenced. Tissue architecture and granulation were improved after the carbohydrate treatment also, since patients that received maltodextrin/ascorbic acid showed lower type I collagen fiber levels and increased extracellular alkaline phosphatase activity and blood vessels than those treated with zinc oxide. We hypothesize that maltodextrin/ascorbic acid treatment stimulated tissue repair of chronic wounds by changing the stage of inflammation and modifying collagen turnover directly through fibroblast response.


Assuntos
Antioxidantes/administração & dosagem , Ácido Ascórbico/administração & dosagem , Polissacarídeos/administração & dosagem , Úlcera Varicosa/tratamento farmacológico , Cicatrização/efeitos dos fármacos , Administração Cutânea , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Colágeno Tipo III/efeitos dos fármacos , Combinação de Medicamentos , Feminino , Humanos , Estudos Longitudinais , Extremidade Inferior , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Estudos Prospectivos , Distribuição Aleatória , Inibidor Tecidual de Metaloproteinase-1/efeitos dos fármacos , Fator de Crescimento Transformador beta1/efeitos dos fármacos , Úlcera Varicosa/microbiologia , Úlcera Varicosa/patologia , Óxido de Zinco/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...